SB Securities

SB Securities is a financial services and investment firm, primarily known as a subsidiary of Sberbank, Russia's largest financial institution. Based in Luxembourg, the company operates as a holding entity and provides brokerage, asset management, and investment services to institutional and private clients. While the firm has been involved in financing activities within the life sciences sector—such as a notable failed $20 million private placement with the biopharmaceutical company NEMUS Bioscience in 2017—it is not a biotechnology or healthcare company itself. In recent years, the company has been subject to international sanctions following geopolitical events involving Russia.